MLTX (MoonLake Immunotherapeutics) Institutional Ownership: 86.31% (As of Jul. 08, 2026)


MLTX MoonLake Immunotherapeutics MLTX
28 GF Score
Price $19.14
! 3 Warning Signs
View Full Analysis

What is MoonLake Immunotherapeutics Institutional Ownership?

MoonLake Immunotherapeutics MLTX +1.43% 28 Institutional Ownership is 86.31% as of Jul. 08, 2026. GuruFocus rates MLTX with a GF Score™ of 28/100. The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, MoonLake Immunotherapeutics's institutional ownership is 86.31%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, MoonLake Immunotherapeutics's Insider Ownership is 5.08%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, MoonLake Immunotherapeutics's Float Percentage Of Total Shares Outstanding is 72.04%.

MoonLake Immunotherapeutics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for MoonLake Immunotherapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MoonLake Immunotherapeutics Institutional Ownership Chart

MoonLake Immunotherapeutics Historical Data

The historical data trend for MoonLake Immunotherapeutics can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 6.97 5.29 5.08 6.55 5.45 5.67 6.02 6.38 7.07 6.16
MLTX
28GF Score
MoonLake Immunotherapeutics MLTX
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MoonLake Immunotherapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 86.31% mean?
MoonLake Immunotherapeutics (MLTX) has a Institutional Ownership of 86.31% as of Jul. 08, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on MoonLake Immunotherapeutics and its competitors.
Is MoonLake Immunotherapeutics' Institutional Ownership too high?
MoonLake Immunotherapeutics' current Institutional Ownership is 86.31%. Overall, MoonLake Immunotherapeutics has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does MoonLake Immunotherapeutics' Institutional Ownership compare to FTRE and SEPN?
MoonLake Immunotherapeutics' Institutional Ownership of 86.31% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on MoonLake Immunotherapeutics and its competitors. MoonLake Immunotherapeutics's current Institutional Ownership is 86.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MoonLake Immunotherapeutics stock overvalued right now?
MoonLake Immunotherapeutics (MLTX) has a current Institutional Ownership of 86.31%. The current Institutional Ownership is 86.31%. MoonLake Immunotherapeutics' overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For MoonLake Immunotherapeutics (MLTX), the current Institutional Ownership is 86.31% as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MoonLake Immunotherapeutics Business Description

Address Dorfstrasse 29, Zug, CHE, 6300
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
28GF Score

Get the complete analysis for MLTX

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.14
Price